* Accelerate Diagnostics Inc AXDX.OQ AXDX.O is expected
to show a rise in quarterly revenue when it reports results on
May 8 for the period ending March 31 2024
* The Denver Colorado-based company is expected to report a
6.7% increase in revenue to $3 million from $2.81 million a year
ago, according to the estimate from one analyst, based on LSEG
data.
* LSEG's mean analyst estimate for Accelerate Diagnostics
Inc is
for a loss of 72 cents per share.
* The one available analyst rating on the shares is "strong
buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
This summary was machine generated May 7 at 02:01 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)